Investment Summary |
|
|---|---|
| Date | 2010-10-08 |
| Target | BioDtech |
| Sector | Life Science |
| Investor(s) | Greer Capital Advisors |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2002 |
| Size | Small |
| Type | Sector Focused |
Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector: Life Science M&A | 6 of 6 |
| Type: Venture M&A Deals | 7 of 7 |
| State: Alabama M&A | 5 of 5 |
| Country: United States M&A | 8 of 8 |
| Year: 2010 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-12-21 |
Applied Genomics
Huntsville, Alabama, United States Applied Genomics, Inc. develops targeted genomics-based diagnostic and therapeutic antibodies for the treatment of cancer. |
Sell | $18M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-12-20 |
Aeon Bioscience
Birmingham, Alabama, United States Aeon Bioscience, Inc. is a developer of a drug-eluting stent, to overcome the current concerns of late stent thrombosis, or blood clot formation at or near the site of the stent and vessel closure due to formation of scar tissue, known as restenosis. Aeon Bioscience was founded in 2007 and is based in Birmingham, Alabama. |
Sell | $255M |
